Serial Number
88655362
Owner
Celgene CorporationAttorney
Marilyn F. KellyFirst Use Date
May 28, 2019
Filing Date
Oct 15, 2019
R2 REVLIMID/RITUXIMAB Trademark
Serial Number: 88655362 • Registration: 6073615
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Marilyn F. Kelly Bristol-Myers Squibb Company
PO BOX 4000
Trademark Dept., Mailstop D.4243
PRINCETON, NJ 08648
United States
Trademark Details
Filing Date
October 15, 2019
Registration Date
June 9, 2020
First Use Anywhere
May 28, 2019
First Use in Commerce
May 28, 2019
Published for Opposition
March 24, 2020
Goods & Services
Medical information and counseling in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; programs in the nature of providing medical information and counseling in the field of lenalidomide and rituximab and safety issues pertaining to lenalidomide and rituximab, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; providing a web site featuring medical information; providing an internet website for medical professionals and medical patients featuring medical information; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmaceutical advice; providing medical information, consultancy and advisory services; all the aforementioned services relating to rituximab
Pharmaceutical preparations for the treatment of certain cancers; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; all the aforementioned goods being comprised in part of rituximab
